# Cardinal Health

> Cardinal Health is a VC fund in Dublin backing Health Care and Medical. See 19 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Dublin, United States
- Total investments: 19
- Last investment: Dec 2025
- Lead investor: 63%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/cardinal-health
- X (Twitter): https://twitter.com/cardinalhealth
- Website: https://www.cardinalhealth.com
- Facebook: https://www.facebook.com/CardinalHealthInc/

Cardinal Health is a Fortune 19 company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals and ambulatory care sites focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability. Cardinal Health employs more than 30,000people worldwide. Cardinal Health focuses on improving people's lives through a link in the chain of care, pharmacies, hospitals, and clinics that rely to improve quality, safety and productivity.

## Contacts

5 contacts available for Cardinal Health. Shizune tracks 8 team members at Cardinal Health. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cardinal-health?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 42% |
| Medical | 4 | 21% |
| Hospital | 3 | 16% |
| Biotechnology | 3 | 16% |
| Internet | 2 | 11% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 21% |
| Series B | 3 | 16% |
| Funding Round | 3 | 16% |
| Corporate Round | 2 | 11% |
| Series C | 1 | 5% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| B.J. Allmon | Platform Product Manager, Connected Care Clinical Platform | 0 | https://shizune.co/investors/profile/b-j-allmon |
| Brian Rice | EVP, CIO, and Global Business Services | 0 | https://shizune.co/investors/profile/brian-rice-6 |
| Donald M. Casey Jr. | Chief Executive Officer, Medical Segment | 0 | https://shizune.co/investors/profile/donald-m-casey-jr |
| Douglas Hoke | Principal Application Security Engineer | 0 | https://shizune.co/investors/profile/douglas-hoke |
| Dustin Studer | Product Manager | 0 | https://shizune.co/investors/profile/dustin-studer |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ember LifeSciences | Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe transport of temperature-sensitive medicines, vaccines, and biologics using proprietary temperature control systems. The company’s core offering includes the Ember Cube. This self-refrigerated and cloud-connected shipping container providescontinuous temperature monitoring, GPS tracking, and real-time data reporting to maintain drug efficacy during transit. Ember LifeSciences leverages its engineering expertise in thermal management and digital monitoring to develop modular shipping solutions that can replace traditional single-use cold chain packaging, thereby reducing waste. It works with pharmaceutical distributors, specialty pharmacies, and laboratories by enabling visibility and control over critical environmental conditions throughout distribution. The company continues to develop next-generation versions of its devices, incorporating improved insulation and configurable features to support broader supply chain use cases. | $20.9M | Series A | Dec 16, 2025 |  |
| Ember LifeSciences | Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe transport of temperature-sensitive medicines, vaccines, and biologics using proprietary temperature control systems. The company’s core offering includes the Ember Cube. This self-refrigerated and cloud-connected shipping container providescontinuous temperature monitoring, GPS tracking, and real-time data reporting to maintain drug efficacy during transit. Ember LifeSciences leverages its engineering expertise in thermal management and digital monitoring to develop modular shipping solutions that can replace traditional single-use cold chain packaging, thereby reducing waste. It works with pharmaceutical distributors, specialty pharmacies, and laboratories by enabling visibility and control over critical environmental conditions throughout distribution. The company continues to develop next-generation versions of its devices, incorporating improved insulation and configurable features to support broader supply chain use cases. | $14.7M | Convertible Note | Aug 10, 2022 |  |
| RxLive | RxLive is a nationwide telehealth platform of clinical pharmacists delivering concierge medication counseling to provider’s patients, employer groups, and consumers. We work with progressive healthcare organizations, employers and payers to integrate pharmacists into the collaborative care team process resulting in improved outcomes and reducedcosts. Our service requires no up-front capital expenditures and delivers a value-added program at a zero-net cost. A hallmark of our process is a focus on motivational interviewing, relationship building and solving the social determinants of non-compliance. Services include: • In-depth pharmacist counselling over videochat or phone • Pharmacogenomic testing with pharmacist consultations • Pharmacist integration into PCMH, CPC+, MSSP and MIPS programs • Post Discharge Medication Reconciliation • Specialty pharmacy cost management • Medication counseling for employees and their extended families | $5M | Series A | Jul 26, 2022 |  |
| Bendcare Management Services Organization | Bendcare Management Services Organization provides management services. |  | Corporate Round | Jul 06, 2022 |  |
| Medically Home | Medically Home is a tech-enabled clinical enterprise that provides all the necessary capabilities to safely-shift medical care from hospitals to patients’ homes. Its platform offers a virtual hospital program that connects patients with caregivers and supports the monitoring of, and communication with patients with high acuity illness that helppatients and their families to access a medical command center that provides centralized, on-demand acute medical care management from the comfort of their homes.The company was founded in 2016 and is headquartered in Boston, Massachusetts. | $110M | Venture - Series Unknown | Jan 10, 2022 |  |
| Medically Home | Medically Home is a tech-enabled clinical enterprise that provides all the necessary capabilities to safely-shift medical care from hospitals to patients’ homes. Its platform offers a virtual hospital program that connects patients with caregivers and supports the monitoring of, and communication with patients with high acuity illness that helppatients and their families to access a medical command center that provides centralized, on-demand acute medical care management from the comfort of their homes.The company was founded in 2016 and is headquartered in Boston, Massachusetts. | $110M | Venture - Series Unknown | Jan 10, 2022 |  |
| Ember LifeSciences | Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe transport of temperature-sensitive medicines, vaccines, and biologics using proprietary temperature control systems. The company’s core offering includes the Ember Cube. This self-refrigerated and cloud-connected shipping container providescontinuous temperature monitoring, GPS tracking, and real-time data reporting to maintain drug efficacy during transit. Ember LifeSciences leverages its engineering expertise in thermal management and digital monitoring to develop modular shipping solutions that can replace traditional single-use cold chain packaging, thereby reducing waste. It works with pharmaceutical distributors, specialty pharmacies, and laboratories by enabling visibility and control over critical environmental conditions throughout distribution. The company continues to develop next-generation versions of its devices, incorporating improved insulation and configurable features to support broader supply chain use cases. |  | Corporate Round | Dec 01, 2021 |  |
| Vineti | Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatmentof late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine.Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016. | $33M | Series C | Oct 13, 2020 |  |
| Vineti | Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatmentof late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine.Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016. | $33M | Series C | Oct 13, 2020 |  |
| Vineti | Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatmentof late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine.Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016. | $35M | Series C | Feb 05, 2020 |  |

10 of 19 investments shown.

## Co-investors
- [Mayo Clinic](https://shizune.co/investors/profile/mayoclinic) — VC Fund, 6 deals together
- [S32](https://shizune.co/investors/profile/section-32) — VC Fund, 6 deals together
- [Canaan Partners](https://shizune.co/investors/profile/canaan-partners) — VC Fund, 4 deals together
- [Casdin Capital](https://shizune.co/investors/profile/casdin-capital) — VC Fund, 4 deals together
- [Lifeforce Capital](https://shizune.co/investors/profile/lifeforce-capital) — VC Fund, 4 deals together
- [Novartis Pharma](https://shizune.co/investors/profile/novartis-pharma) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Cardinal Health invest in?

Cardinal Health invests primarily in Health Care, Medical and Hospital startups, most often at Series A and Series B stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cardinal Health?

Public channels for Cardinal Health include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Cardinal Health?

The team at Cardinal Health includes B.J. Allmon (Platform Product Manager, Connected Care Clinical Platform), Brian Rice (EVP, CIO, and Global Business Services) and Donald M. Casey Jr. (Chief Executive Officer, Medical Segment), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co